Decreased choroidal thickness could increase VEGF

Article

Decreased choroidal thickness could increase vascular endothelial growth factor (VEGF) and cause tissue hypoxia.

Decreased choroidal thickness could increase vascular endothelial growth factor (VEGF) and cause tissue hypoxia.

Dr Giuseppe Querques et al., Department of Ophthalmology, University Vita Salute San Raffaele, Milan, Italy, studied a total of 63 eyes of 63 diabetic patients either without diabetic retinopathy (NDR), with diabetic retinopathy [nonproliferative diabetic retinopathy (NPDR)] and no clinically significant macular oedema (CSME).

The mean best-corrected visual acuity was 0.13 ± 0.25 LogMAR and the mean central macular thickness (CMT) was 272.5 ± 16.2 μm in 21 NDR eyes, 294.5 ± 23.5 μm in 21 NPDR/CSME− eyes, and 385.6 ± 75.1 μm in 21 NPDR/CSME+ eyes.

There were no differences in mean subfoveal choroidal thickness between each diabetic group. However, in each diabetic group the mean subfoveal choroidal thickness was significantly reduced compared to the control group.

An overall thinning of the choroid on EDI OCT was witnessed in diabetic eyes. This could lead to tissue hypoxia and could increase VEGF levels, meaning the blood-retinal barrier could break down and cause macular oedema.

The abstract for the study was printed in the Investigative Journal of Ophthalmology.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.